The enigmatic protist Nephromyces.

Biosystems

Published: June 1982

This paper review current knowledge concerning the identity of Nephromyces, a collection of fungus-like cells found in the renal sac of all molgulid tunicates thus far examined. The following has been demonstrated: (1) The cells called Nephromyces do exist, and are not produced by their tunicate hosts, but are something foreign to these animals. (2) Many forms of "Nephromyces" cells are present simultaneously in the renal sac of adults of each molgulid species. Despite their extraordinarily eclectic appearance, all these cells are part of the same life cycle. (3) Initial ultrastructural data indicate that Nephromyces is a eukaryote. They also suggest that, despite the speculations of early authors, Nephromyces may not be a Chytridiomycete.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0303-2647(81)90052-6DOI Listing

Publication Analysis

Top Keywords

renal sac
8
nephromyces
5
enigmatic protist
4
protist nephromyces
4
nephromyces paper
4
paper review
4
review current
4
current knowledge
4
knowledge concerning
4
concerning identity
4

Similar Publications

Background: Understanding the association of tobacco product use with subclinical markers is essential in evaluating health effects to inform regulatory policy. This is particularly relevant for noncigarette products (eg, cigars, pipes, and smokeless tobacco), which have been understudied because of their low prevalence in individual cohort studies.

Methods: This cross-sectional study included 98 450 participants from the Cross-Cohort Collaboration-Tobacco data set.

View Article and Find Full Text PDF

Inadvertent exposure to aristolochic acids (AAs) is causing chronic renal disease worldwide, with aristolochic acid I (AA-I) identified as the primary toxic agent. This study employed chemical methods to investigate the mechanisms underlying the nephrotoxicity and carcinogenicity of AA-I. Aristolochic acid II (AA-II), which has a structure similar to that of AA-I, was investigated with the same methods for comparison.

View Article and Find Full Text PDF

: The parallel stent graft endovascular aortic repair (PGEVAR) technique is an off-the-shelf option used for elective complex abdominal aortic aneurysm repair with acceptable outcome results, as reported so far. The PGEVAR technique, using chimney or periscope parallel grafts, can also be used for patients with ruptured complex abdominal aortic aneurysms. However, only few data about the mid- to long-term outcomes are available.

View Article and Find Full Text PDF

Aims: Whether prior treatment with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) modifies efficacy and safety of sacubitril/valsartan (Sac/Val) in patients with heart failure (HF) and ejection fraction (EF) >40% is unclear, thus Sac/Val according to ACEi/ARB status at baseline was assessed.

Methods And Results: This was a pre-specified analysis of Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE-HF), a double-blind, randomized controlled trial of Sac/Val versus valsartan, categorizing patients according to baseline ACEi/ARB status. The primary endpoint was time-averaged proportional change in N-terminal pro-B-type natriuretic peptide (NT-proBNP) from baseline through weeks 4 and 8.

View Article and Find Full Text PDF

Introduction: Cardiac tamponade is a life-threatening condition resulting from fluid accumulation in the pericardial sac, leading to decreased cardiac output and shock. Various etiologies can cause cardiac tamponade, including liver cirrhosis, which may be induced by autoimmune hepatitis. Autoimmune hepatitis is a chronic inflammatory liver disease characterized by interface hepatitis, elevated transaminase levels, autoantibodies, and increased immunoglobulin G levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!